| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |